HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the appointment of Alan K. Smith, Ph.D., as Senior Vice President of Manufacturing.
“We are pleased to welcome an executive with Alan’s level of expertise in the cellular immunotherapy field,” said Tom Farrell, Bellicum’s President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
